The Interim Sub-analysis from APEX Part 1+2 Studies; Efficacy and Safety of Dimethyl Fumarate in Treatment-naive Japanese Patients with Relapse-remitting MS

被引：0
|
作者：
Mori, M. [1 ]
Ohashi, T. [2 ]
Onizuka, Y. [3 ]
Hiramatsu, K. [3 ]
Hase, M. [3 ,4 ]
Yun, J. [4 ]
Torii, S. [3 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan
[2] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Neurol, Chiba, Japan
[3] Biogen Japan Ltd, Tokyo, Japan
[4] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-43
引用
收藏
页码：456 / 457
页数：2
相关论文
共 33 条
  • [31] Efficacy and Safety of Lersivirine (UK-453,061) Versus Efavirenz in Antiretroviral Treatment-Naive HIV-1-Infected Patients: Week 48 Primary Analysis Results From an Ongoing, Multicenter, Randomized, Double-Blind, Phase IIb Trial
    Vernazza, Pietro
    Wang, Cunshan
    Pozniak, Anton
    Weil, Elizabeth
    Pulik, Piotr
    Cooper, David. A.
    Kaplan, Richard
    Lazzarin, Adriano
    Valdez, Hernan
    Goodrich, James
    Mori, Julie
    Craig, Charles
    Tawadrous, Margaret
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (02) : 171 - 179
  • [32] Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China
    Wei, Lai
    Xu, Xiaoyun
    Guan, Yujuan
    Zheng, Sujun
    Sheng, Jifang
    Yang, Xingxiang
    Ma, Yuanji
    Huang, Yan
    Kang, Yi
    Wen, Xiaofeng
    Li, Jun
    Tan, Youwen
    He, Qing
    Xie, Qing
    Wang, Maorong
    An, Ping
    Gong, Guozhong
    Liu, Huimin
    Ning, Qin
    Hua, Rui
    Ning, Bo
    Xie, Wen
    Zhang, Jiming
    Huang, Wenxiang
    Yang, Yongfeng
    Lin, Minghua
    Zhao, Yingren
    Yu, Yanhong
    Jia, Jidong
    Yang, Dongliang
    Chen, Liang
    Ye, Yinong
    Nan, Yuemin
    Gong, Zuojiong
    Zhang, Quan
    Hu, Peng
    Wang, FuSheng
    Li, Yongguo
    Li, Dongliang
    Jia, Zhansheng
    Hou, Jinlin
    Chen, Chengwei
    Wu, Jinzi
    HEPATOLOGY, 2018, 68 : 584A - 584A
  • [33] Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study
    Tobe, Kazuyuki
    Maegawa, Hiroshi
    Tabuchi, Hiromi
    Nakamura, Ichiro
    Uno, Satoshi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (05) : 1262 - 1271
1234